click below
click below
Normal Size Small Size show me how
Ch 7 Key Terms
study stack for this weeks chapter 7 key terms quiz
| Term | Definition |
|---|---|
| Agranulocytosis | a reduction in white blood cells |
| alcohol dependence | a pattern of alcohol use that involves problems controlling drinking and preoccupation with alcohol, Alcoholism |
| anorexia | loss of appetite for food |
| antipsychotic drugs | drugs that are used to treat schizophrenia; reduce symptoms of hallucinations, delusions, and thought disorders |
| anxiety | a state of uneasiness characterized by apprehension and worry about possible events |
| atypical antipsychotic drugs | first line therapy for schizophrenia and other psychoses that address specific neurotransmitters |
| bipolar disorder | a condition in which a patient presents with mood swings that alternate between periods of major depression and periods of mild to severe chronic agitation |
| cataplexy | short periods of muscle weakness and loss of muscle tone associated with sudden emotions such as joy, fear, or anger, a symptom of narcolepsy |
| chemical dependence | the inability to control the use of some physical substance |
| delirium tremens (DTS) | a condition caused by cessation of alcohol consumption in which coarse, irregular tremors are accompanied by vivid hallucinations |
| depression | a condition characterized by anxiety, hopelessness, irritability, intense sadness, loss of concentration, pessimism, and problems with eating and sleeping |
| emetic | a substance that induces vomiting |
| endogenous anxiety | anxiety caused by factors within the organism |
| exogenous anxiety | anxiety caused by factors outside the organism |
| extrapyramidal side effects (EPS) | disorders of muscle movement caused by blocking dopamine receptors in the basal ganglia |
| ghost tablet | an empty shell of an OROS tablet, excreted in the stool after the drug has dissolved |
| hypnotic | a drug that induces sleep |
| insomnia | difficulty failing asleep or staying asleep, or not feeling refreshed on awakening |
| mania | a state of overly high energy, excitement, hyperactivity, optimism, and increased psychomotor activity |
| monoamino oxidase inhibitor | an antidepressant drug that inhibits the activity of the enzymes that break down catecholamines, such as norepinephrine, and serotonin |
| narcolepsy | a sleep disorder in which inappropriate attacks of sleep during the daytime hours |
| neuroleptic drugs | see antipsychotic drugs |
| neurotransmitter | a chemical substance emitted by a neuron to communicate such as serotonin, dopamine, or norepinephrine |
| orthostatic hypotension | a drop in bp on sitting or standing up |
| osmotic controlled release oral delivery system | a drug delivery system that allows the drug to dissolve through pores in the tablet shell, the empty shell, called a ghost tablet, is passed in the stool intense |
| panic | overwhelming and uncontrollable anxiety |
| posttraumatic stress disorder | a disorder characterized by persistent agitation or persistent, recurring fear after the end of a traumatic event and lasting for over a month or impairing work or relationships |
| permenstrual dysphoric disorder | a severe form of PMS |
| priapism | a prolonged penile erection |
| QT interval | the time between depolarization and repolarization of the ventricles of the heart during a heartbeat, as shown on an electrocardiogram |
| schizophrenia | a chronic mental health disorder with mental and emotional fragmentation and retreat from reality, hallucinations, ambivalence, and bizarre or regressive behaviors |
| seasonal affective disorder | a form of depression that recurs in the fall and winter and remits in the spring and summer |
| selective serotonin reuptake inhibitors | an antidepressant drug that blocks the reabsorption of serotonin, with little effect on norepinephrine and fewer effect than other antidepressant drugs |
| serotonin norepinephrine reuptake inhibitor | an antidepressant drug that blocks the reabsoprtion of both serotonin and norepinephrine increasing the levels of both neurotransmitters |
| serotonin syndrome | a possibly fatal condition caused by combining antidepressants that increase serotonin levels with other medications that also stimulate seotonin receptors |
| tardive dyskinesia | involuntary movements of the mouth, lips, and tongue |
| tricyclic antidepressants | one of a class of antidepressant drugs developed earlier than the ssris and snris that also prevent neuron reuptake of norepinephrine and/or serotonin |
| washout period | the time period one must wait before changing drug therapies so the first drug is out of the patients system before the new drug takes effect |